Hudkræftklinikken.dk ApS: Financial statements 2023
CVR: 38219960
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Hudkræftklinikken.dk ApS (CVR 38219960) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,290,159 and a net result of DKK -210,507 compared with DKK -363,008 the year before. That is a decrease of 0.1% compared with the year before. Equity in the 2023 report amounted to DKK 1,588,065. The solvency ratio was 58%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,290,159
- Profit/Loss
- DKK -210,507
- Equity
- DKK 1,588,065
- Total Assets
- DKK 2,738,502
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.3M | -211K | 1.6M | 2 |
| 2022 | - | 1.3M | -363K | 1.2M | 2 |
| 2021 | - | 1.8M | 557K | 2.6M | 2 |
| 2020 | - | 1.7M | 167K | 2.4M | - |
| 2019 | - | 2.1M | -819K | 2.2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of June 12, 2023, PHOENIX CAPITAL ApS is registered as an owner of Hudkræftklinikken.dk ApS with an ownership share of 10%.
Hudkræftklinikken.dk ApS has published its annual report for 2022. Gross profit came to DKK 1,291,638, and the net result was DKK -363,008.
About Hudkræftklinikken.dk ApS
Hudkræftklinikken.dk ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Hudkræftklinikken.dk Anpartsselskab. The management consists of Bolette Birch Bengtsen. The board consists of Robert Birger Birch (chair), Kent Stevens Larsen and Martin Glud. The company's owners include Birch Bengtsen Invest ApS, PHOENIX CAPITAL ApS and M.Glud holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. Equity in the 2025 report amounted to DKK 757,000.